Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Liver Diseases

  Free Subscription


Articles published in AJR Am J Roentgenol

Retrieve available abstracts of 120 articles:
HTML format



Single Articles


    April 2024
  1. CALLIADA F
    Editorial Comment: Multiparametric Ultrasound Assessment of Hepatic Fat Fraction in a Real-World Population.
    AJR Am J Roentgenol. 2024 Apr 3. doi: 10.2214/AJR.24.31226.
    PubMed    


    March 2024
  2. KUBALE R, Schneider G, Lessenich CPN, Buecker A, et al
    Ultrasound-Derived Fat Fraction for Hepatic Steatosis Assessment: Prospective Study of Agreement With MRI PDFF and Sources of Variability in a Heterogeneous Population.
    AJR Am J Roentgenol. 2024 Mar 20. doi: 10.2214/AJR.23.30775.
    PubMed     Abstract available


    January 2024
  3. KIELAR A
    Editorial Comment: Radiologists' Roles and Opportunities in Alcohol-Associated Liver Disease.
    AJR Am J Roentgenol. 2024;222:e2330296.
    PubMed    


  4. SQUIRES JH
    Editorial Comment: A Role for Assessing Liver Stiffness by Shear-Wave Elastography in Patients With Fontan Circulation.
    AJR Am J Roentgenol. 2024;222:e2330073.
    PubMed    


  5. SHANBHOGUE K
    Editorial Comment: MR Elastography of the Liver-Practical Guidelines for Optimal Clinical Use.
    AJR Am J Roentgenol. 2024;222:e2329642.
    PubMed    


  6. CHAVHAN GB, Kim JH, Squires JH, Toso S, et al
    The Global Reading Room: An Incidental Liver Lesion in a Teenager.
    AJR Am J Roentgenol. 2024;222:e2329350.
    PubMed    


    December 2023
  7. KING KG
    Editorial Comment: Perfluorobutane Increases Sensitivity and Accuracy in Hepatocellular Carcinoma Diagnosis Compared With Purely Intravascular Contrast Agents.
    AJR Am J Roentgenol. 2023 Dec 6. doi: 10.2214/AJR.23.30601.
    PubMed    


    November 2023
  8. KANG HJ, Lee JM, Yoon JH, Yoo J, et al
    Contrast-Enhanced Ultrasound With Perfluorobutane for Hepatocellular Carcinoma Diagnosis: Comparison of Imaging Phases and Diagnostic Criteria.
    AJR Am J Roentgenol. 2023 Nov 22. doi: 10.2214/AJR.23.30156.
    PubMed     Abstract available


    October 2023
  9. ZHANG LX, Tang A
    Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Counterpoint-Hepatobiliary Contrast Agents Improve Detection and Characterization.
    AJR Am J Roentgenol. 2023 Oct 4. doi: 10.2214/AJR.23.30140.
    PubMed    


  10. TAMANDL D, Schima W
    Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Point-Why Extracellular Contrast Agents Are Superior for This Task.
    AJR Am J Roentgenol. 2023 Oct 4. doi: 10.2214/AJR.23.30254.
    PubMed    


  11. CAO JJ, Kwon DH, Ghaziani TT, Kwo P, et al
    Accuracy of Information Provided by ChatGPT Regarding Liver Cancer Surveillance and Diagnosis.
    AJR Am J Roentgenol. 2023;221:556-559.
    PubMed    


    September 2023
  12. MAHESHWARI S, Gu CN, Caserta MP, Kezer CA, et al
    Imaging of Alcohol-Associated Liver Disease.
    AJR Am J Roentgenol. 2023 Sep 20. doi: 10.2214/AJR.23.29917.
    PubMed     Abstract available


  13. LAN T, Wei B
    Proper Hepatic Artery Pseudoaneurysm Treated by Endovascular Stent.
    AJR Am J Roentgenol. 2023 Sep 13. doi: 10.2214/AJR.23.30088.
    PubMed    


    August 2023
  14. DERINKUYU BE, Dillman JR, Lubert AM, Palermo JJ, et al
    Associations of Liver Stiffness Measured by Ultrasound Shear-Wave Elastography With Portal Hypertension and Circulatory Failure in Individuals With Fontan Circulation.
    AJR Am J Roentgenol. 2023 Aug 2. doi: 10.2214/AJR.23.29640.
    PubMed     Abstract available


    July 2023
  15. MURAKAMI T
    Editorial Comment: Hepatic Steatosis-Contrast-Enhanced CT Is a Leading Mark.
    AJR Am J Roentgenol. 2023 Jul 26. doi: 10.2214/AJR.23.29953.
    PubMed    


  16. ARKOUDIS NA
    Editorial Comment: Implementing Deep Learning to Extrapolate Hepatic Proton-Density Fat Fraction From T1-Weighted In-Phase and Opposed-Phase MRI.
    AJR Am J Roentgenol. 2023 Jul 19. doi: 10.2214/AJR.23.29918.
    PubMed    


  17. WANG K, Cunha GM, Hasenstab K, Henderson WC, et al
    Deep Learning for Inference of Hepatic Proton-Density Fat Fraction From T1-Weighted In-Phase and Opposed-Phase MRI: Retrospective Analysis of Population-Based Trial Data.
    AJR Am J Roentgenol. 2023 Jul 19. doi: 10.2214/AJR.23.29607.
    PubMed     Abstract available


  18. PICKHARDT PJ, Blake GM, Kimmel Y, Weinstock E, et al
    Detection of Moderate Hepatic Steatosis on Portal Venous Phase Contrast-Enhanced CT: Evaluation Using an Automated Artificial Intelligence Tool.
    AJR Am J Roentgenol. 2023 Jul 19. doi: 10.2214/AJR.23.29651.
    PubMed     Abstract available


    June 2023
  19. DEIPOLYI AR, Ward RC, Riaz A, Vogl TJ, et al
    Locoregional Therapies for Primary and Metastatic Breast Cancer: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2023 Jun 28. doi: 10.2214/AJR.23.29454.
    PubMed     Abstract available


  20. TROUT AT, Taylor AE, Kasten JL, Castro-Rojas C, et al
    Corrected T1 Mapping in Children and Young Adults With Autoimmune Liver Disease: Correlation With Histology.
    AJR Am J Roentgenol. 2023;220:901-902.
    PubMed     Abstract available


  21. YU H
    Editorial Comment: Thermal Ablation Plus Systemic Chemotherapy in Colorectal Cancer Liver Oligometastases-The Optimal Sequence and Timing.
    AJR Am J Roentgenol. 2023;220:900.
    PubMed    


  22. LI J, Yu J, Liu G, Xie X, et al
    Up-Front Versus Delayed Thermal Ablation for Colorectal Liver Oligometastases: A Multicenter Retrospective Study Using Propensity Score Matching.
    AJR Am J Roentgenol. 2023;220:885-899.
    PubMed     Abstract available


    May 2023
  23. YIN M, Ehman RL
    MR Elastography: Practical Questions, From the AJR Special Series on Imaging of Fibrosis.
    AJR Am J Roentgenol. 2023 May 10. doi: 10.2214/AJR.23.29437.
    PubMed     Abstract available


    February 2023
  24. TORKIAN P, Haghshomar M, Farsad K, Wallace S, et al
    Cancer Immunology: Impact of Radioembolization of Hepatocellular Carcinoma on Immune Response Modulation.
    AJR Am J Roentgenol. 2023 Feb 8. doi: 10.2214/AJR.22.28800.
    PubMed     Abstract available


    January 2023
  25. WANG X, Liang W
    Any Hepatic Lesion That Is Classified as LR-M Shall Not Be Ignored.
    AJR Am J Roentgenol. 2023 Jan 4:1. doi: 10.2214/AJR.22.28553.
    PubMed    


  26. MIN JH, Lee MW
    Reply to "Any Hepatic Lesion That Is Classified as LR-M Shall Not Be Ignored".
    AJR Am J Roentgenol. 2023 Jan 4:1-2. doi: 10.2214/AJR.22.28614.
    PubMed    


  27. KIM TH, Woo S, Ebrahimzadeh S, Mclnnes MDF, et al
    Reply to "Hepatic Adenomas With Hepatobiliary Phase Iso- or Hyperintensity: Standardized Definitions Are Required".
    AJR Am J Roentgenol. 2023 Jan 4:1-2. doi: 10.2214/AJR.22.28513.
    PubMed    


  28. TSE JR
    Hepatic Adenomas With Hepatobiliary Phase Iso- or Hyperintensity: Standardized Definitions Are Required.
    AJR Am J Roentgenol. 2023 Jan 4:1. doi: 10.2214/AJR.22.28471.
    PubMed    


    December 2022
  29. YU H
    Editorial Comment: Complete Pathologic Necrosis of Early Hepatocellular Carcinoma After Pre-Liver Transplant Locoregional Therapy-Why Does It Matter?
    AJR Am J Roentgenol. 2022 Dec 7. doi: 10.2214/AJR.22.28816.
    PubMed    


  30. SARWAR A, Bonder A, Hassan L, Malik MS, et al
    Factors Associated With Complete Pathologic Necrosis of Hepatocellular Carcinoma on Explant Evaluation After Locoregional Therapy: A National Analysis Using the UNOS Database.
    AJR Am J Roentgenol. 2022 Dec 7. doi: 10.2214/AJR.22.28385.
    PubMed     Abstract available


  31. SWENSSON J
    Editorial Comment: Expanding the Contrast-Enhanced Ultrasound Toolbox With Perfluorobutane Microbubble Contrast Agents.
    AJR Am J Roentgenol. 2022 Dec 7. doi: 10.2214/AJR.22.28784.
    PubMed    


    November 2022
  32. LI L, Mao S, Wang J, Zheng W, et al
    Intraindividual Comparison of Contrast-Enhanced Ultrasound Using Perfluorobutane With Modified Criteria Versus CT/MRI LI-RADS Version 2018 for Diagnosing HCC in High-Risk Patients.
    AJR Am J Roentgenol. 2022 Nov 16. doi: 10.2214/AJR.22.28420.
    PubMed     Abstract available


    October 2022
  33. FETZER DT
    Reply to "Underdiagnosis of High-Risk Liver Diseases Leads to Inadequate Ultrasound Screening for Hepatocellular Carcinoma".
    AJR Am J Roentgenol. 2022 Oct 12:2. doi: 10.2214/AJR.22.28134.
    PubMed    


  34. KUO SE, Lin YJ, Wang JD
    Underdiagnosis of High-Risk Liver Diseases Leads to Inadequate Ultrasound Screening for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2022 Oct 12:1-2. doi: 10.2214/AJR.22.28079.
    PubMed    


  35. GIAN RK
    Editorial Comment: An Algorithm to Distinguish Between Hepatocellular Adenoma Subtypes on Gadoxetate Disodium-Enhanced MRI.
    AJR Am J Roentgenol. 2022 Oct 12. doi: 10.2214/AJR.22.28613.
    PubMed    


  36. SRINIVASAN A
    Editorial Comment: Intravascular Ultrasound Facilitates TIPS Creation.
    AJR Am J Roentgenol. 2022;219:646.
    PubMed    


  37. RONOT M
    Editorial Comment: The Influence of Steatosis on Liver Stiffness Measurement-A Call for Caution, but Limited Clinical Consequences.
    AJR Am J Roentgenol. 2022;219:613.
    PubMed    


  38. KUMADA T, Toyoda H, Yasuda S, Ogawa S, et al
    Liver Stiffness Measurements by 2D Shear-Wave Elastography: Effect of Steatosis on Fibrosis Evaluation.
    AJR Am J Roentgenol. 2022;219:604-612.
    PubMed     Abstract available


    September 2022
  39. TSE JR, Felker ER, Cao JJ, Naini BV, et al
    Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
    AJR Am J Roentgenol. 2022 Sep 28. doi: 10.2214/AJR.22.28233.
    PubMed     Abstract available


  40. MAGNETTA MJ
    Editorial Comment: Is It Time to Focus on LR-M?
    AJR Am J Roentgenol. 2022;219:433.
    PubMed    


    August 2022
  41. BORHANI AA
    Editorial Comment: MRI-Based Machine-Learning Model for Prediction of Recurrence in Early Stage Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2022 Aug 31. doi: 10.2214/AJR.22.28432.
    PubMed    


  42. KIM TK
    Editorial Comment: Differentiating Hepatic Adenomas From Focal Nodular Hyperplasias With Gadoxetic Acid-Enhanced MRI-More Complicated Than Thought.
    AJR Am J Roentgenol. 2022 Aug 17. doi: 10.2214/AJR.22.28384.
    PubMed    


  43. ISEKE S, Zeevi T, Kucukkaya AS, Raju R, et al
    Machine-Learning Models for Prediction of Posttreatment Recurrence in Early-Stage Hepatocellular Carcinoma Using Pretreatment Clinical and MRI Features: A Proof-of-Concept Study.
    AJR Am J Roentgenol. 2022 Aug 17. doi: 10.2214/AJR.22.28077.
    PubMed     Abstract available


  44. KIM TH, Woo S, Ebrahimzadeh S, Mclnnes MDF, et al
    Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2022 Aug 3. doi: 10.2214/AJR.22.27989.
    PubMed     Abstract available


  45. TAFFEL M, Petrocelli RD, Rigau D, Schieda N, et al
    Prevalence of Malignancy in Adrenal Nodules with Heterogeneous Microscopic Fat on Chemical-Shift MRI: A Multiinstitutional Study.
    AJR Am J Roentgenol. 2022 Aug 3. doi: 10.2214/AJR.22.27976.
    PubMed     Abstract available


  46. TAVRI S
    Editorial Comment: FIPS Score-A New Tool With Improved Potential to Predict Post-TIPS Outcomes.
    AJR Am J Roentgenol. 2022;219:268.
    PubMed    


  47. CUNHA GM, Delgado TI, Middleton MS, Liew S, et al
    Automated CNN-Based Analysis Versus Manual Analysis for MR Elastography in Nonalcoholic Fatty Liver Disease: Intermethod Agreement and Fibrosis Stage Discriminative Performance.
    AJR Am J Roentgenol. 2022;219:224-232.
    PubMed     Abstract available


    July 2022
  48. CANNELLA R
    Editorial Comment: LI-RADS Provides High Accuracy for Liver Transplant Eligibility in High-Risk Patients.
    AJR Am J Roentgenol. 2022;219:96.
    PubMed    


  49. HUBER AT, Obmann V
    Beyond the AJR: Prognostic Value of a Single Baseline Liver Stiffness Measurement by MR Elastography in Patients With Chronic Liver Disease.
    AJR Am J Roentgenol. 2022;219:169.
    PubMed    


    June 2022
  50. BARR RG
    Editorial Comment: How Imaging Can Manage the Fatty Liver Epidemic.
    AJR Am J Roentgenol. 2022 Jun 22. doi: 10.2214/AJR.22.28113.
    PubMed    


  51. INOUE A, Voss BA, Lee NJ, Takahashi H, et al
    Diagnostic Performance in Low- and High-Contrast Tasks of an Image-Based Denoising Algorithm Applied to Radiation Dose-Reduced Multiphase Abdominal CT Examinations.
    AJR Am J Roentgenol. 2022 Jun 22. doi: 10.2214/AJR.22.27806.
    PubMed     Abstract available


  52. TSE JR, Shen L, Bird KN, Yoon L, et al
    Outcomes of LI-RADS US-2 Subthreshold Observations Detected on Surveillance Ultrasound.
    AJR Am J Roentgenol. 2022 Jun 15. doi: 10.2214/AJR.22.27812.
    PubMed     Abstract available


  53. DILLMAN JR, Thapaliya S, Tkach JA, Trout AT, et al
    Quantification of Hepatic Steatosis by Ultrasound: Prospective Comparison to MRI Proton-Density Fat Fraction as Reference Standard.
    AJR Am J Roentgenol. 2022 Jun 8. doi: 10.2214/AJR.22.27878.
    PubMed     Abstract available


  54. BASTAWROUS S
    Editorial Comment: Factors Impacting Ultrasound LI-RADS Visualization Scores-Optimizing Future Quality Assurance and Standards.
    AJR Am J Roentgenol. 2022;218:1020.
    PubMed    


    May 2022
  55. HULL NC
    Editorial Comment: Hepatocellular Carcinoma Screening Guidelines Are Needed in Children With Predisposing Conditions.
    AJR Am J Roentgenol. 2022 May 18. doi: 10.2214/AJR.22.27975.
    PubMed    


  56. DASTMALCHIAN S, Aryafar H, Tavri S
    Intravascular Ultrasound Guidance for Transjugular Intrahepatic Portosystemic Shunt Procedures: A Review.
    AJR Am J Roentgenol. 2022 May 18. doi: 10.2214/AJR.22.27626.
    PubMed     Abstract available


  57. KIM SH, Navot B, Guniganti P, Gavlin A, et al
    Liver Transplant for Non-Hepatocellular Malignancies: A Review for Radiologists.
    AJR Am J Roentgenol. 2022 May 11. doi: 10.2214/AJR.22.27783.
    PubMed     Abstract available


  58. REES MA, Schooler GR, Chavhan GB, Towbin AJ, et al
    Imaging Features of Hepatocellular Carcinoma in Children With and Without Underlying Risk Factors.
    AJR Am J Roentgenol. 2022 May 11. doi: 10.2214/AJR.22.27600.
    PubMed     Abstract available


  59. LUNA A
    Editorial Comment: Integrated Diagnosis of Hepatocellular Carcinoma-An Opportunity for Abdominal Radiologists.
    AJR Am J Roentgenol. 2022 May 4:12. doi: 10.2214/AJR.22.27611.
    PubMed    


  60. CANNELLA R, Lewis S, da Fonseca L, Ronot M, et al
    Immunotherapy-Based Treatments of Hepatocellular Carcinoma: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2022 May 4. doi: 10.2214/AJR.22.27633.
    PubMed     Abstract available


    April 2022
  61. KING KG
    Editorial Comment: Future Incorporation of Kupffer-Cell Agents Into Contrast-Enhanced Ultrasound LI-RADS May Increase Sensitivity for HCC Without Compromising Specificity.
    AJR Am J Roentgenol. 2022 Apr 27. doi: 10.2214/AJR.22.27857.
    PubMed    


  62. LI L, Zheng W, Wang J, Han J, et al
    Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection.
    AJR Am J Roentgenol. 2022 Apr 20. doi: 10.2214/AJR.22.27521.
    PubMed     Abstract available


  63. WANG X, Guo Y, Yang L, Luo X, et al
    Use of an Intrahepatic Arterial Targeting Wire for Guiding Portal Vein Puncture During TIPS Creation in Patients With Obliterative Portal Vein Thrombosis.
    AJR Am J Roentgenol. 2022 Apr 13. doi: 10.2214/AJR.22.27675.
    PubMed     Abstract available


  64. KURTZ D, Wachsberg RH
    Factitious Nodularity of the Anterior Liver Surface on Prone Abdominal CT: A Potential Mimic of Cirrhosis.
    AJR Am J Roentgenol. 2022 Apr 13. doi: 10.2214/AJR.22.27669.
    PubMed    


  65. TIYARATTANACHAI T, Fetzer DT, Kamaya A
    Multicenter Study of ACR Ultrasound LI-RADS Visualization Scores on Serial Examinations: Implications for Changes in Surveillance Strategies.
    AJR Am J Roentgenol. 2022 Apr 6. doi: 10.2214/AJR.22.27405.
    PubMed     Abstract available


  66. FETZER DT
    Beyond the AJR: Shorter Ultrasound Screening Intervals for Hepatocellular Carcinoma Improve Patient Outcomes.
    AJR Am J Roentgenol. 2022;218:761.
    PubMed    


    March 2022
  67. LI J, Yin M
    Liver Fibrosis: Counterpoint-MR Elastography Is the Noninvasive Imaging Modality of Choice for Detecting and Staging Liver Fibrosis.
    AJR Am J Roentgenol. 2022 Mar 23. doi: 10.2214/AJR.22.27676.
    PubMed    


  68. PIERCE TT, Samir AE
    Liver Fibrosis: Point-Ultrasound Elastography Is a Safe, Widely Available, Low-Cost, Noninvasive Biomarker of Liver Fibrosis That Is Suitable for Broad Community Use.
    AJR Am J Roentgenol. 2022 Mar 23. doi: 10.2214/AJR.22.27639.
    PubMed    


  69. MIN JH, Lee MW, Park HS, Lee DH, et al
    LI-RADS Version 2018 Targetoid Appearances on Gadoxetic Acid-Enhanced MRI: Interobserver Agreement and Diagnostic Performance for the Differentiation of HCC and Non-HCC Malignancy.
    AJR Am J Roentgenol. 2022 Mar 23. doi: 10.2214/AJR.22.27380.
    PubMed     Abstract available


  70. YOUNG S
    Editorial Comment: Echocardiography-Should It Be Routine Before Elective TIPS?
    AJR Am J Roentgenol. 2022 Mar 2. doi: 10.2214/AJR.22.27580.
    PubMed    


  71. TANG A
    Editorial Comment: LI-RADS LR-2 and LR-3 Observations-Benign or Not Benign?
    AJR Am J Roentgenol. 2022;218:471.
    PubMed    


    February 2022
  72. ALI A, Sarwar A, Patwardhan VR, Fraiche AM, et al
    Echocardiographic and Other Preprocedural Predictors of Heart Failure After TIPS Placement in Patients With Cirrhosis: A Single-Center 15-Year Analysis.
    AJR Am J Roentgenol. 2022 Feb 16. doi: 10.2214/AJR.21.26947.
    PubMed     Abstract available


  73. LOY LM, Low HM, Choi JY, Rhee HJ, et al
    Variant Hepatocellular Carcinoma Subtypes According to the 2019 WHO Classification: An Imaging-Focused Review.
    AJR Am J Roentgenol. 2022 Feb 16. doi: 10.2214/AJR.21.26982.
    PubMed     Abstract available


  74. BAE JS, Lee DH, Lee SM, Suh KS, et al
    Performance of LI-RADS Version 2018 on CT for Determining Eligibility for Liver Transplantation According to Milan Criteria in Patients at High Risk for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2022 Feb 9. doi: 10.2214/AJR.21.27186.
    PubMed     Abstract available


  75. YANG C, Chen Q, Zhou C, Liu J, et al
    FIPS Score for Prediction of Survival After TIPS Placement: External Validation and Comparison With Traditional Risk Scores in a Cohort of Chinese Patients With Cirrhosis.
    AJR Am J Roentgenol. 2022 Feb 9. doi: 10.2214/AJR.21.27301.
    PubMed     Abstract available


  76. MELLNICK VM
    Editorial Comment: Increased liver lesion visualization on CT without increased cost.
    AJR Am J Roentgenol. 2022 Feb 2. doi: 10.2214/AJR.22.27391.
    PubMed    


  77. GEE MS
    Editorial Comment: Novel Associations Between Quantitative MRI Metrics and Clinical Risk Scores in Young Patients With Autoimmune Liver Disease.
    AJR Am J Roentgenol. 2022 Feb 2. doi: 10.2214/AJR.22.27453.
    PubMed    


    January 2022
  78. MCCRARY J, Trout AT, Mahalingam N, Singh R, et al
    Associations Between Quantitative MRI Metrics and Clinical Risk Scores in Children and Young Adults With Autoimmune Liver Disease.
    AJR Am J Roentgenol. 2022 Jan 26. doi: 10.2214/AJR.21.27204.
    PubMed     Abstract available


  79. CHO KJ
    Editorial Comment: Bland Hepatic Artery Embolization (HAE) for Hepatic Malignancy-Can Bland HAE be Performed on an Outpatient Basis?
    AJR Am J Roentgenol. 2022 Jan 19. doi: 10.2214/AJR.22.27384.
    PubMed    


  80. BONGERS MN, Walter S, Fritz J, Bier G, et al
    Interindividual Comparison of Frequency-Selective Nonlinear Blending to Conventional CT for Detection of Focal Liver Lesions Using MRI as the Reference Standard.
    AJR Am J Roentgenol. 2022 Jan 12. doi: 10.2214/AJR.21.26922.
    PubMed     Abstract available


  81. RMILAH AA, Qrareya MN, Fleming C, Alkurashi AK, et al
    Association of Cirrhosis and Other Patient and Procedural Characteristics With Postembolization Syndrome after Bland Hepatic Artery Embolization for Hepatic Malignancy.
    AJR Am J Roentgenol. 2022 Jan 5. doi: 10.2214/AJR.21.26806.
    PubMed     Abstract available


  82. DILLMAN JR, Franck MD, Gandhi D, Pednekar AS, et al
    Agreement Between Automated and Clinically Reported Manual ROI-Based MR Elastography Liver Stiffness Measurements in Children and Young Adults.
    AJR Am J Roentgenol. 2022;218:163-164.
    PubMed     Abstract available


    December 2021
  83. XIAN MF, Huang Y, Xie WX, Pan KM, et al
    LR-M Observations on Contrast-Enhanced Ultrasound: Detection of Hepatocellular Carcinoma Using Additional Features in Comparison with Current LI-RADS Criteria.
    AJR Am J Roentgenol. 2021 Dec 15. doi: 10.2214/AJR.21.26837.
    PubMed     Abstract available


  84. LIU PS
    Editorial Comment: Is Quantitative CT Fat Fraction Ready For Prime Time?
    AJR Am J Roentgenol. 2021 Dec 15. doi: 10.2214/AJR.21.27184.
    PubMed    


  85. FETZER DT, Browning T, Xi Y, Yokoo T, et al
    Associations of Ultrasound LI-RADS Visualization Score With Examination-, Sonographer-, and Radiologist-Factors: Retrospective Assessment in Over 10,000 Examinations.
    AJR Am J Roentgenol. 2021 Dec 15. doi: 10.2214/AJR.21.26735.
    PubMed     Abstract available


  86. SCHIMA W
    Editorial Comment: Which MRI Contrast Agent for Hepatocellular Carcinoma Diagnosis in LI-RADS? The Fog is Lifting.
    AJR Am J Roentgenol. 2021 Dec 8. doi: 10.2214/AJR.21.27171.
    PubMed    


    November 2021
  87. GUO Z, Blake GM, Graffy PM, Sandfort V, et al
    Hepatic Steatosis: CT-based Prevalence in Adults in China and the United States and Associations with Age, Sex, and Body Mass Index.
    AJR Am J Roentgenol. 2021 Nov 24. doi: 10.2214/AJR.21.26728.
    PubMed     Abstract available


  88. RONG D, He B, Tang W, Xie S, et al
    Comparison of Gadobenate-Enhanced MRI and Gadoxetate-Enhanced MRI for Hepatocellular Carcinoma Detection Using LI-RADS Version 2018: A Prospective Intraindividual Randomized Study.
    AJR Am J Roentgenol. 2021 Nov 24. doi: 10.2214/AJR.21.26818.
    PubMed     Abstract available


    October 2021
  89. HAO F, Eghbalieh N, So A, Lee EW, et al
    Hepatic Plexus Nerve Block for Microwave Ablation of Hepatic Tumors.
    AJR Am J Roentgenol. 2021 Oct 27. doi: 10.2214/AJR.21.26779.
    PubMed     Abstract available


  90. STRUYCKEN L, Patel M, Kuo P, Hennemeyer C, et al
    Clinical and Dosimetric Implications of Calculating Lung Shunt Fraction for Hepatic Yttrium-90 Radioembolization Using SPECT/CT Versus Planar Scintigraphy.
    AJR Am J Roentgenol. 2021 Oct 27. doi: 10.2214/AJR.21.26663.
    PubMed     Abstract available


  91. CHERNYAK V
    Editorial Comment: Transitional or Hepatobiliary Phase Hypointensity Improves Sensitivity Without Loss of Specificity for Pathologically Viable HCC After Locoregional Treatment.
    AJR Am J Roentgenol. 2021 Oct 20. doi: 10.2214/AJR.21.26949.
    PubMed    


  92. CHERNYAK V, van der Pol CB, Vernuccio F, Yoshimitsu K, et al
    The Global Reading Room: Imaging Detection of Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Oct 13. doi: 10.2214/AJR.21.26909.
    PubMed    


  93. RANATHUNGA D, Osman H, Islam N, McInnes MD, et al
    Progression Rates of LR-2 and LR-3 Observations on MRI to Higher LI-RADS Categories in Patients at High Risk for Hepatocellular Carcinoma: A Retrospective Study.
    AJR Am J Roentgenol. 2021 Oct 13. doi: 10.2214/AJR.21.26376.
    PubMed     Abstract available


  94. LIU J, Ma J, Yang C, Ye T, et al
    Reply to "Factors in Spleen Size After TIPS Placement".
    AJR Am J Roentgenol. 2021;217:1013.
    PubMed    


  95. GEMERY JM, Munger DP, Hoffer EK
    Factors in Spleen Size After TIPS Placement.
    AJR Am J Roentgenol. 2021;217:1013.
    PubMed    


  96. FERRAIOLI G
    Beyond the AJR: "Two-Dimensional Shear Wave Elastography Predicts Survival in Advanced Chronic Liver Disease".
    AJR Am J Roentgenol. 2021;217:1012.
    PubMed    


  97. D'HONDT A, Rubesova E, Xie H, Shamdasani V, et al
    Liver Fat Quantification by Ultrasound in Children: A Prospective Study.
    AJR Am J Roentgenol. 2021;217:996-1006.
    PubMed     Abstract available


    September 2021
  98. DOHARE N, Madhusudhan KS, Malik R, Das P, et al
    Utility of Hepatic 2D Shear-Wave Elastography in Monitoring Response to Image-Guided Intervention in Children With Chronic Budd-Chiari Syndrome: A Prospective Study.
    AJR Am J Roentgenol. 2021 Sep 29. doi: 10.2214/AJR.21.26547.
    PubMed     Abstract available


  99. KIM YY, Kim MJ, Yoon JK, Shin J, et al
    Incorporation of Ancillary MRI Features into the LI-RADS Treatment Response Algorithm: Impact on Diagnostic Performance After Locoregional Treatment for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Sep 29. doi: 10.2214/AJR.21.26677.
    PubMed     Abstract available


  100. REIZINE E, Chalaye J, Mule S, Regnault H, et al
    Utility of Early Posttreatment PET/CT Evaluation Using FDG or (18)F-FCH to Predict Response to (90)Y Radioembolization in Patients With Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Sep 8. doi: 10.2214/AJR.21.26485.
    PubMed     Abstract available


    August 2021
  101. SHARBIDRE KG
    Editorial Comment: Recurrence of Hepatocellular Carcinoma in Liver Transplants-Microvascular Invasion and Pathologic Staging of the Explant Liver.
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.26681.
    PubMed    


  102. CUNHA GM, Hosseini M, Furlan A, Fowler K, et al
    Hepatocellular Carcinoma Staging: Differences Between Radiologic and Pathologic Systems and Relevance to Patient Selection and Outcomes in Liver Transplantation.
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.26436.
    PubMed     Abstract available


    July 2021
  103. SEVCO TJ, Masch WR, Maturen KE, Mendiratta-Lala M, et al
    Ultrasound (US) LI-RADS: Outcomes of Category US-3 Observations.
    AJR Am J Roentgenol. 2021 Jul 14:1-7. doi: 10.2214/AJR.20.23447.
    PubMed     Abstract available


  104. PAUL RK, Vazirani R, McDermott JC, Kliewer MA, et al
    Identification of the Most Important Subset of Doppler, Laboratory, and Clinical Parameters for Serial TIPS Evaluation.
    AJR Am J Roentgenol. 2021;217:164-171.
    PubMed     Abstract available


    June 2021
  105. CHU HH, Kim JH, Shin YM, Won HJ, et al
    Percutaneous Radiofrequency Ablation for Recurrent Intrahepatic Cholangiocarcinoma After Curative Resection: Multivariable Analysis of Factors Predicting Survival Outcomes.
    AJR Am J Roentgenol. 2021 Jun 2:1-7. doi: 10.2214/AJR.20.23461.
    PubMed     Abstract available


  106. ARAKI T, Imaizumi A, Okada H, Sasaki Y, et al
    Anatomy of Left Inferior Phrenic Vein in Patients Without Portal Hypertension.
    AJR Am J Roentgenol. 2021 Jun 2:1-7. doi: 10.2214/AJR.20.23106.
    PubMed     Abstract available


    May 2021
  107. RIDDELL AM, Torkzad MR, Koh DM
    Reply to "Additional Considerations on Use of Abbreviated Liver MRI in Patients With Colorectal Liver Metastases".
    AJR Am J Roentgenol. 2021 May 19:W1-W2. doi: 10.2214/AJR.21.25747.
    PubMed    


  108. GRANATA V, Fusco R, Petrillo A
    Additional Considerations on Use of Abbreviated Liver MRI in Patients With Colorectal Liver Metastases.
    AJR Am J Roentgenol. 2021 May 19:W1. doi: 10.2214/AJR.21.25652.
    PubMed    


  109. MALONE CD
    Editorial Comment on "Ultrasound-Guided Portal Vein Access and Percutaneous Wire Placement in the Portal Vein Are Associated With Shorter Procedure Times and Lower Radiation Doses During TIPS Placement".
    AJR Am J Roentgenol. 2021;216:1299.
    PubMed    


    April 2021
  110. ROBBINS AJ, Ritter S, Markese M, Skube ME, et al
    Atypical Hepatic Steatosis Patterns on MRI After Total Pancreatectomy With Islet Autotransplant.
    AJR Am J Roentgenol. 2021 Apr 28:1-7. doi: 10.2214/AJR.20.23303.
    PubMed     Abstract available


  111. CHAVHAN GB, Yoo SJ, Lam CZ, Khanna G, et al
    Abdominal Imaging of Children and Young Adults With Fontan Circulation: Pathophysiology and Surveillance.
    AJR Am J Roentgenol. 2021 Apr 28:1-11. doi: 10.2214/AJR.20.23404.
    PubMed     Abstract available


  112. SQUIRES JH, McCarville MB
    Contrast-Enhanced Ultrasound in Children: Implementation and Key Diagnostic Applications.
    AJR Am J Roentgenol. 2021 Apr 28. doi: 10.2214/AJR.21.25713.
    PubMed     Abstract available


  113. KIM B, Won JH, Kim J, Kwon Y, et al
    Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma: Radiologic and Clinical Factors Predictive of Survival.
    AJR Am J Roentgenol. 2021 Apr 14:1-8. doi: 10.2214/AJR.20.23213.
    PubMed     Abstract available


  114. CHEN Y, Xia Y, Tolat PP, Long L, et al
    Comparison of Conventional Gadoxetate Disodium-Enhanced MRI Features and Radiomics Signatures With Machine Learning for Diagnosing Microvascular Invasion.
    AJR Am J Roentgenol. 2021 Apr 7:1-11. doi: 10.2214/AJR.20.23255.
    PubMed     Abstract available


  115. FERRAIOLI G, Barr RG
    Quantification of Liver Steatosis: Is CT Equivalent to PDFF?
    AJR Am J Roentgenol. 2021;216:W14.
    PubMed    


  116. CORNMAN-HOMONOFF J, Madoff DC
    Commentary on: "Rebleeding and Mortality Risk Are Increased by ACLF but Reduced by Pre-emptive TIPS".
    AJR Am J Roentgenol. 2021;216:878.
    PubMed    


    February 2021
  117. RIEDESEL EL
    Editorial Comment: Liver Fat Quantification by Ultrasound-Potential to Change Diagnosis and Management of Pediatric NAFLD.
    AJR Am J Roentgenol. 2021 Feb 10. doi: 10.2214/AJR.21.25594.
    PubMed    


  118. VAN DER POL CB, Dhindsa K, Shergill R, Zha N, et al
    MRI Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Impact of and Reduction in Ancillary Features.
    AJR Am J Roentgenol. 2021 Feb 3:1-8. doi: 10.2214/AJR.20.23031.
    PubMed     Abstract available


    September 2020
  119. BORHANI AA
    Editorial Comment on "Liver Steatosis Categorization on Contrast-Enhanced CT Using a Fully-Automated Deep Learning Volumetric Segmentation Tool: Evaluation in 1,204 Heathy Adults Using Unenhanced CT as Reference Standard".
    AJR Am J Roentgenol. 2020 Sep 30. doi: 10.2214/AJR.20.24764.
    PubMed    


  120. PICKHARDT PJ, Blake GM, Graffy PM, Sandfort V, et al
    Liver Steatosis Categorization on Contrast-Enhanced CT Using a Fully-Automated Deep Learning Volumetric Segmentation Tool: Evaluation in 1,204 Heathy Adults Using Unenhanced CT as Reference Standard.
    AJR Am J Roentgenol. 2020 Sep 16. doi: 10.2214/AJR.20.24415.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.